EUVIMEDFaigh amach EUVIMED
CrossrefCárta eolais

Red Blood Cell Exchange in a Resource‐Variable Setting: A Scoping Review of Two Decades of Indian Experience

Radheshyam Meher, Raj Narayan Swain, Anushree Mandal, Shravani Subhedar

Journal of Clinical Apheresis · 2026-12 · 41 (6)

DOI: 10.1002/jca.70213 ↗
AchoimreSonraí leabharliosta

Achoimre

ABSTRACT Red blood cell exchange enables rapid reduction of pathological erythrocytes but requires substantial transfusion, apheresis, and immunohematology support. Following JBI methodology and PRISMA‐ScR guidance, this scoping review mapped the indications, techniques, outcomes, transfusion support and implementation considerations of RBC exchange in India. Thirty‐nine publications from 14 Indian States and Union Territories were included (2000–2026), of which 74.4% were published from 2020 onwards. Most were case reports (56.4%) and case series (28.2%), with no randomized or controlled trial. Sickle cell disease and related disorders were the predominant indications (76.9%), followed by methemoglobinemia (25.6%) and severe malaria (7.7%). Practice evolved from manual and resource‐adapted approaches towards increasing use of automated exchanges. Substantial reductions in pathological erythrocyte fractions were reported, although clinical outcomes, transfusion requirements and procedural safety were inconsistently documented. Alloimmunization and compatible‐unit procurement presented additional challenges. Published Indian experience demonstrates expanding use and technical feasibility across diverse settings. However, the evidence remains descriptive and uncontrolled, with limited data on comparative effectiveness, long‐term outcomes, safety, and cost‐effectiveness. Standardized reporting, systematic hemovigilance, prospective multicenter studies, and registry‐based surveillance are future priorities.

Eolas a oireann do do chuid oibre.

Ó thús saor in aisce agus taighde litríochta pearsanta go dtí an Research Suite iomlán.

Féach ar na taraifí →

An bhfuil gach téacs iomlán ó fhoilsitheoirí san áireamh?

Ní hea. Is ábhair éagsúla iad tagairtí bibleagrafaíocha, achoimrí agus lánthéacsanna. Braitheann fáil an lánthéacs ar an bhfoinse, Open Access agus ar na ceadúnais atá agat cheana. Ní chuireann taraif EUVIMED cearta breise foilsitheora ina n-ionad.

Féach ar na taraifí →